var data={"title":"Ciclopirox: Pediatric drug information","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"drugTitle\">Ciclopirox: Pediatric drug information</div><div id=\"lexiTitleImg\"></div><div class=\"clear\"></div><div id=\"lcoSearchClickUrl\"><a href=\"http://online.lexi.com/lco/action/api/find/globalid/5898?utd=1\" target=\"_blank\">Access Lexicomp Online here.</a></div><div id=\"drugCopy\">Copyright 1978-2018 Lexicomp, Inc. All rights reserved.</div><div id=\"topicText\">(For additional information <a href=\"topic.htm?path=ciclopirox-drug-information\" class=\"drug drug_general\">see &quot;Ciclopirox: Drug information&quot;</a> and <a href=\"topic.htm?path=ciclopirox-patient-drug-information\" class=\"drug drug_patient\">see &quot;Ciclopirox: Patient drug information&quot;</a>)<br></br>For abbreviations and symbols that may be used in Lexicomp (<a href=\"image.htm?imageKey=DRUG%2F57469\" class=\"graphic graphic_table\">show table</a>)<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F151212\" class=\"list ubnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: US</span>\n    <ul>\n      <li>Ciclodan;</li>\n      <li>Ciclodan Cream;</li>\n      <li>Ciclodan Solution;</li>\n      <li>Ciclopirox Treatment;</li>\n      <li>CNL8 Nail [DSC];</li>\n      <li>Loprox;</li>\n      <li>Pedipirox-4 Nail [DSC];</li>\n      <li>Penlac</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F151213\" class=\"list cbnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: Canada</span>\n    <ul>\n      <li>Apo-Ciclopirox;</li>\n      <li>Loprox;</li>\n      <li>Penlac;</li>\n      <li>PMS-Ciclopirox;</li>\n      <li>Stieprox;</li>\n      <li>Taro-Ciclopirox</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F1005707\" class=\"list_set htclist drugH1Div drugBrandNames\"><span class=\"drugH1\">Therapeutic Category</span>\n    <ul>\n      <li>\n        <span class=\"list-set-name\">Antifungal Agent, Topical</span></li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F1005732\" class=\"block dos drugH1Div\"><span class=\"drugH1\">Dosing: Usual</span><p>(For additional information <a href=\"topic.htm?path=ciclopirox-drug-information\" class=\"drug drug_general\">see &quot;Ciclopirox: Drug information&quot;</a>)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Pediatric:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Cutaneous candidiasis, tinea cruris, and tinea versicolor:</b> Cream and suspension (lotion): Children &ge;10 years and Adolescents: Topical:  Apply twice daily (morning and evening) to the affected area; if no improvement after 4 weeks, reevaluate treatment</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Tinea corporis, tinea pedis: </b></p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Cream and suspension (lotion): Children &ge;10 years and Adolescents: Topical:  Apply twice daily (morning and evening) to the affected area; if no improvement after 4 weeks, reevaluate treatment</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Gel: Adolescents &ge;16 years: Topical: Apply twice daily (morning and evening) to affected areas and surrounding skin; if no improvement after 4 weeks of treatment, reevaluate diagnosis</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Onychomycosis of the fingernails and toenails:</b> Lacquer (solution): Children &ge;12 years and Adolescents: Topical: Apply to adjacent skin and affected nails once daily preferably at bedtime or 8 hours before washing (as a part of a comprehensive management program for onychomycosis). Remove with alcohol every 7 days.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Seborrheic dermatitis of the scalp:</b> Adolescents &ge;16 years: Topical: </p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Gel: Apply twice daily, gently massage into affected areas and surrounding skin; if no improvement after 4 weeks of treatment, reevaluate diagnosis</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Shampoo: Apply ~5 mL to wet hair; lather, and leave in place ~3 minutes; rinse. May use up to 10 mL for longer hair. Repeat twice weekly for 4 weeks; allow a minimum of 3 days between applications; if no improvement after 4 weeks of treatment, reevaluate diagnosis</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Adult:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Cutaneous candidiasis, tinea cruris, and tinea versicolor:</b> Topical: Cream and suspension: Apply twice daily, gently massage into affected areas; if no improvement after 4 weeks of treatment, reevaluate the diagnosis</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Tinea corporis, tinea pedis:</b> Topical: </p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Cream and suspension (lotion): Apply twice daily, gently massage into affected areas; if no improvement after 4 weeks of treatment, reevaluate the diagnosis</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Gel: Apply twice daily, gently massage into affected areas and surrounding skin; if no improvement after 4 weeks of treatment, reevaluate diagnosis </p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Onychomycosis of the fingernails and toenails:</b> Topical: Lacquer (solution): Apply to adjacent skin and affected nails daily (as a part of a comprehensive management program for onychomycosis). Remove with alcohol every 7 days.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Seborrheic dermatitis of the scalp:</b> Topical:</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Gel: Apply twice daily, gently massage into affected areas and surrounding skin; if no improvement after 4 weeks of treatment, reevaluate diagnosis</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Shampoo: Apply ~5 mL to wet hair; lather, and leave in place ~3 minutes; rinse. May use up to 10 mL for longer hair. Repeat twice weekly for 4 weeks; allow a minimum of 3 days between applications; if no improvement after 4 weeks of treatment, reevaluate diagnosis</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Dosing adjustment in renal impairment:</b>  There are no dosage adjustments provided in the manufacturer's labeling.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Dosing adjustment in hepatic impairment:</b>  There are no dosage adjustments provided in the manufacturer's labeling.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F151195\" class=\"block foc drugH1Div\"><span class=\"drugH1\">Dosage Forms</span>\n    <p style=\"text-indent:0em;text-align:justify;display:inline\">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Cream, External, as olamine [strength expressed as base]: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Ciclodan: 0.77% (90 g) [contains benzyl alcohol, cetyl alcohol]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Loprox: 0.77% (90 g) [contains benzyl alcohol, cetyl alcohol]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 0.77% (15 g, 30 g, 90 g)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Gel, External: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Loprox: 0.77% (100 g [DSC]) [contains isopropyl alcohol]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 0.77% (30 g, 45 g, 100 g)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Kit, External: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Ciclodan Cream: 0.77% [contains benzyl alcohol, cetyl alcohol, edetate disodium, propylene glycol]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Ciclodan Solution: 8% [contains edetate disodium, isopropyl alcohol, menthol]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Ciclopirox Treatment: 8% [contains edetate disodium, isopropyl alcohol, menthol]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">CNL8 Nail: 8% [DSC] [contains isopropyl alcohol]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Loprox: 0.77% [contains benzyl alcohol, cetyl alcohol]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Loprox: 0.77% [contains benzyl alcohol, cetyl alcohol, edetate disodium, propylene glycol]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Pedipirox-4 Nail: 8% [DSC] [contains isopropyl alcohol]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 8 % [DSC]</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Shampoo, External: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Loprox: 1% (120 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 1% (120 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Solution, External: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Ciclodan: 8% (6.6 mL) [contains isopropyl alcohol]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Penlac: 8% (6.6 mL) [contains ethyl acetate, isopropyl alcohol]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 8% (6.6 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Suspension, External, as olamine [strength expressed as base]: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Loprox: 0.77% (60 mL) [contains benzyl alcohol, cetyl alcohol]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 0.77% (30 mL, 60 mL)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F151182\" class=\"block geq drugH1Div\"><span class=\"drugH1\">Generic Availability (US)</span>\n    <p style=\"text-indent:0em;display:inline\">Yes</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F1005736\" class=\"block adm drugH1Div\"><span class=\"drugH1\">Administration</span>\n    <p style=\"text-indent:0em;display:inline\">Topical: For topical use only; not for ophthalmic, oral, or intravaginal use.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Cream, gel, suspension (lotion): Gently massage into affected areas and surrounding skin in the morning and evening. Avoid contact with eyes and mucous membranes; do not administer orally or intravaginally. Do not occlude affected area with dressings or wrappings. Shake suspension (lotion) vigorously before application.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Shampoo: Apply to wet hair and scalp, lather, and leave in place ~3 minutes; rinse thoroughly. Avoid contact with eyes.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Solution (lacquer): Apply evenly over the entire nail plate and 5 mm of surrounding skin using the applicator brush; allow to dry for 30 seconds; apply at bedtime (or allow 8 hours before washing). Solution can be reapplied daily over previous applications; remove with alcohol every 7 days. After ciclopirox is removed with alcohol, file away (with emery board) loose nail material and trim nails, as required or as directed by a health care professional. Avoid contact with eyes and mucous membranes; do not administer orally or intravaginally. Do not use nail polish or other nail cosmetic products on the treated nails.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F151209\" class=\"block sts drugH1Div\"><span class=\"drugH1\">Storage/Stability</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Cream, gel, shampoo: Store at 15&deg;C to 30&deg;C (59&deg;F to 86&deg;F).</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Nail lacquer (solution): Store at 15&deg;C to 30&deg;C (59&deg;F to 86&deg;F). Protect from light. Flammable; keep away from heat and flame.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Suspension: Store at 5&deg;C to 25&deg;C (41&deg;F to 77&deg;F).</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F1005708\" class=\"block use drugH1Div\"><span class=\"drugH1\">Use</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Cream/suspension (lotion): Treatment of cutaneous candidiasis, tinea pedis, tinea cruris, tinea versicolor, and tinea corporis (FDA approved in ages &ge;10 years and adults) </p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Gel: Treatment of tinea corporis, interdigital tinea pedis, and treatment of seborrheic dermatitis of the scalp (FDA approved in ages &ge;16 years and adults)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Shampoo: Treatment of seborrheic dermatitis of the scalp (FDA approved in ages &ge;16 years and adults)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Solution (lacquer): Treatment of mild to moderate onychomycosis of fingernails and toenails (not involving the lunula) in immunocompetent patients (FDA approved in ages &ge;12 years and adults)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F151248\" class=\"block arm drugH1Div\"><span class=\"drugH1\">Adverse Reactions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Cardiovascular: Facial edema, ventricular tachycardia (shampoo)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Central nervous system: Headache </p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Dermatologic: Acne vulgaris, alopecia, contact dermatitis, erythema, hair discoloration (rare; shampoo formulation in light-haired individuals), localized erythema, nail disease (shape or color change with lacquer), pruritus, skin rash, xeroderma</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Local: Application site burning (more common in gel), local irritation, local pain</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Ophthalmic: Eye pain</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F151200\" class=\"block coi drugH1Div\"><span class=\"drugH1\">Contraindications</span>\n    <p style=\"text-indent:0em;display:inline\">Hypersensitivity to ciclopirox or any component of the formulation</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F151186\" class=\"block war drugH1Div\"><span class=\"drugH1\">Warnings/Precautions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Concerns related to adverse effects:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Irritation: Discontinue if sensitivity or irritation occurs and institute appropriate therapy.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Special populations:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Immunocompromised patients: Use with caution; use has not been evaluated in immunosuppressed or immunocompromised patients.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Dosage form specific issues:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Benzyl alcohol and derivatives: Some dosage forms may contain benzyl alcohol; large amounts of benzyl alcohol (&ge;99 mg/kg/day) have been associated with a potentially fatal toxicity (&quot;gasping syndrome&quot;) in neonates; the &quot;gasping syndrome&quot; consists of metabolic acidosis, respiratory distress, gasping respirations, CNS dysfunction (including convulsions, intracranial hemorrhage), hypotension and cardiovascular collapse (AAP [&quot;Inactive&quot; 1997]; CDC 1982); some data suggests that benzoate displaces bilirubin from protein binding sites (Ahlfors 2001); avoid or use dosage forms containing benzyl alcohol with caution in neonates. See manufacturer&rsquo;s labeling.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Nail lacquer: For topical use only; has not been studied in conjunction with systemic therapy or in patients with type 1 diabetes mellitus (insulin dependent, IDDM) or diabetic neuropathy.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Shampoo: Patients with lighter hair color may experience hair discoloration.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Other warnings/precautions: </i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Appropriate use: For topical use only; avoid contact with eyes or mucous membranes. Use of occlusive dressings or wrappings should be avoided.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F26522861\" class=\"block add-pediatric-warn-info drugH1Div\"><span class=\"drugH1\">Warnings: Additional Pediatric Considerations</span>\n    <p style=\"text-indent:0em;display:inline\">Some dosage forms may contain propylene glycol; in neonates large amounts of propylene glycol delivered orally, intravenously (eg, &gt;3,000 mg/day), or topically have been associated with potentially fatal toxicities which can include metabolic acidosis, seizures, renal failure, and CNS depression; toxicities have also been reported in children and adults including hyperosmolality, lactic acidosis, seizures and respiratory depression; use caution (AAP 1997; Shehab 2009).</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F13299041\" class=\"block cyt drugH1Div\"><span class=\"drugH1\">Metabolism/Transport Effects</span>\n    <p style=\"text-indent:0em;display:inline\">None known.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F151190\" class=\"block dri drugH1Div\"><span class=\"drugH1\">Drug Interactions</span>\n    <br/><br/><div id=\"lexiInteractAddInfo\" class=\"lexi\">(For additional information: <a href=\"https://www.uptodate.com/drug-interactions/?search=&amp;topicId=13063&amp;source=responsive_topic\" class=\"dip\" target=\"_blank\">Launch drug interactions program</a>)</div><div id=\"lexiInteractImgB\" class=\"lexi\"><img src=\"/images/lexiComp/Lexicomp_2012_71x17.gif\" width=\"71\" height=\"17\" border=\"0\"/></div><div class=\"clear\"></div><p style=\"text-indent:0em;display:inline\">There are no known significant interactions.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F151192\" class=\"block prf drugH1Div\"><span class=\"drugH1\">Pregnancy Risk Factor</span>\n    <p style=\"text-indent:0em;display:inline\">B (<a href=\"image.htm?imageKey=DRUG%2F50021\" class=\"graphic graphic_table\">show table</a>)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F151202\" class=\"block pri drugH1Div\"><span class=\"drugH1\">Pregnancy Implications</span>\n    <p style=\"text-indent:0em;display:inline\">Adverse events were not observed in animal reproduction studies. </p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F5598923\" class=\"block mop drugH1Div\"><span class=\"drugH1\">Monitoring Parameters</span>\n    <p style=\"text-indent:0em;display:inline\">Resolution of skin or nail infection</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F151185\" class=\"block pha drugH1Div\"><span class=\"drugH1\">Mechanism of Action</span>\n    <p style=\"text-indent:0em;display:inline\">Inhibiting transport of essential elements in the fungal cell disrupting the synthesis of DNA, RNA, and protein</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F151199\" class=\"block phk drugH1Div\"><span class=\"drugH1\">Pharmacodynamics/Kinetics (Adult data unless noted)</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Absorption: Cream, suspension: 1.3% through intact skin; increased with gel; &lt;5% with lacquer</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Distribution: Scalp application: To epidermis, corium (dermis), including hair, hair follicles, and sebaceous glands</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Metabolism: Conjugated with glucuronic acid</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Half-life elimination: Biologic: Cream, suspension: 1.7 hours; Elimination: Gel: 5.5 hours</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Excretion: Urine (Gel: 3% to 10%; Shampoo: &lt;0.5%; Cream, suspension: 0.01%); feces (small amounts)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F151201\" class=\"block fee drugH1Div\"><span class=\"drugH1\">Pricing: US</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Cream</b> (Ciclodan External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">0.77% (90 g): $496.64</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Cream</b> (Ciclopirox Olamine External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">0.77% (30 g): $56.50</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Cream</b> (Loprox External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">0.77% (90 g): $357.12</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Gel</b> (Ciclopirox External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">0.77% (45 g): $121.45</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Kit</b> (Ciclodan Cream External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">0.77% (544 g): $496.64</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Kit</b> (Ciclodan Solution External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">8% (34.6 mL): $420.44</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Kit</b> (Loprox External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">0.77% (544 g): $357.12</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">0.77% (Susp) (1): $321.49</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Shampoo</b> (Ciclopirox External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1% (120 mL): $147.35</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Shampoo</b> (Loprox External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1% (120 mL): $1,038.29</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Solution</b> (Ciclodan External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">8% (6.6 mL): $420.44</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Solution</b> (Ciclopirox External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">8% (6.6 mL): $60.18</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Solution</b> (Penlac External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">8% (6.6 mL): $1,352.51</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Suspension</b> (Ciclopirox Olamine External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">0.77% (30 mL): $48.80</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Suspension</b> (Loprox External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">0.77% (60 mL): $321.49</p>\n    <p style=\"text-indent:0em;\">\n      <b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F151203\" class=\"list fbnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: International</span>\n    <ul>\n      <li>Batrafan (IN);</li>\n      <li>Batrafen (AE, AT, BB, BD, BG, BH, BM, BS, BZ, CH, CL, CR, CY, CZ, DE, DO, EC, EE, EG, GT, GY, HN, HR, HU, ID, IQ, IR, IT, JM, JO, JP, KW, LB, LY, NI, NL, NZ, OM, PA, PE, PK, PL, PR, PY, QA, RU, SA, SG, SK, SR, SV, SY, TR, TT, UY, VE, YE);</li>\n      <li>Batrafen Gel (DE);</li>\n      <li>Batrafen Nail Lacquer (IL);</li>\n      <li>Brumixol (IT, TW);</li>\n      <li>Candirox (BD);</li>\n      <li>Canolen (TR);</li>\n      <li>Ciclochem (ES);</li>\n      <li>Clopirox (BD);</li>\n      <li>Fungirox (BR);</li>\n      <li>Gidacid (CR, DO, HN, NI, PA, SV);</li>\n      <li>Huanli (CN);</li>\n      <li>Loprox (AR, BR, EC, MX, TH);</li>\n      <li>Loprox Laca (MX);</li>\n      <li>Loprox Nail Lacquer (ID);</li>\n      <li>Loprox Naillacquer (KR);</li>\n      <li>Miclast (ES, IT);</li>\n      <li>Micopirox (AR);</li>\n      <li>Micoxolamina (IT);</li>\n      <li>Mycofen (DK);</li>\n      <li>Myconail (IL);</li>\n      <li>Mycoster (AE, FR, HR, IL, JO, KW, LB, LU, PT, VN);</li>\n      <li>Nail Batrafen (NZ);</li>\n      <li>Naillacquer (KR);</li>\n      <li>Nobiprox (KR);</li>\n      <li>Olamin (LK);</li>\n      <li>Onytec (LV);</li>\n      <li>Penlac (BM);</li>\n      <li>Primax (CO);</li>\n      <li>Sebiprox (ES, KR, MT);</li>\n      <li>Stieprox (AU, CZ, FI, GR, IE, LK, MY, PH, QA, SA, SG, SK, TH, TW);</li>\n      <li>Stiprox (MX, PE)</li></ul></div>\r\n</div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\">\r\n<li>\r\n<div class=\"reference\">\n    Ahlfors CE. Benzyl alcohol, kernicterus, and unbound bilirubin. <i>J Pediatr</i>. 2001;139(2):317-319.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/ciclopirox-pediatric-drug-information/abstract-text/11487763 /pubmed\" target=\"_blank\" id=\"11487763 \">11487763 </a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    American Academy of Pediatrics Committee on Drugs. &quot;Inactive&quot; ingredients in pharmaceutical products: update (subject review). <i>Pediatrics</i>. 1997;99(2):268-278.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/ciclopirox-pediatric-drug-information/abstract-text/9024461/pubmed\" target=\"_blank\" id=\"9024461\">9024461</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Barber K, Claveau J, and Thomas R, &quot;Review of Treatment for Onychomycosis: Consideration for Special Populations,&quot; <i>J Cutan Med Surg</i>, 2006, 10(Suppl 2):S48-53.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/ciclopirox-pediatric-drug-information/abstract-text/17204233/pubmed\" target=\"_blank\" id=\"17204233\">17204233</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Centers for Disease Control (CDC). Neonatal deaths associated with use of benzyl alcohol - United States. <i>MMWR Morb Mortal Wkly Rep</i>. 1982;31(22):290-291. <a>http://www.cdc.gov/mmwr/preview/mmwrhtml/00001109.htm</a><span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/ciclopirox-pediatric-drug-information/abstract-text/6810084 /pubmed\" target=\"_blank\" id=\"6810084 \">6810084 </a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Ciclodan cream (ciclopirox) [prescribing information]. Fairfield, NJ: Medimetriks Pharmaceuticals, Inc; June 2012.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Ciclodan solution (ciclopirox) [prescribing information]. Fairfield, NJ: Medimetriks Pharmaceuticals, Inc; March 2011.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Ciclopirox gel [prescribing information]. Melville, NY: Fougera &amp; Co; October 2013.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Ciclopirox suspension [prescribing information]. Allegan, MI: Perrigo; October 2014.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    CNL8 solution (ciclopirox) [prescribing information]. Charleston, SC: Innocutis Holdings LLC; December 2011. </div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Gallup E, Plott T, and Ciclopirox TS Investigators, &quot;A Multicenter, Open-Label Study to Assess the Safety and Efficacy of Ciclopirox Topical Suspension 0.77% in the Treatment of Diaper Dermatitis Due to <i>Candida albicans</i>,&quot;<i> J Drugs Dermatol</i>, 2005, 4(1):29-34.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/ciclopirox-pediatric-drug-information/abstract-text/15696982/pubmed\" target=\"_blank\" id=\"15696982\">15696982</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Loprox shampoo (ciclopirox) [prescribing information]. Scottsdale, AZ: Medicis, The Dermatology Company; May 2013. </div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Penlac solution (ciclopirox) [prescribing information]. Bridgewater, NJ: Valeant Pharmaceuticals; May 2013.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Shehab N, Lewis CL, Streetman DD, Donn SM. Exposure to the pharmaceutical excipients benzyl alcohol and propylene glycol among critically ill neonates. <i>Pediatr Crit Care Med</i>. 2009;10(2):256-259.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/ciclopirox-pediatric-drug-information/abstract-text/19188870/pubmed\" target=\"_blank\" id=\"19188870\">19188870</a>]</span></div>\r\n</li></ol></div><div id=\"topicVersionRevision\">Topic 13063 Version 151.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul><li class=\"plainItem\"><a sectionName=\"Brand Names: US\" href=\"#F151212\" class=\"outlineLink\">Brand Names: US</a></li><li class=\"plainItem\"><a sectionName=\"Brand Names: Canada\" href=\"#F151213\" class=\"outlineLink\">Brand Names: Canada</a></li><li class=\"plainItem\"><a sectionName=\"Therapeutic Category\" href=\"#F1005707\" class=\"outlineLink\">Therapeutic Category</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Usual\" href=\"#F1005732\" class=\"outlineLink\">Dosing: Usual</a></li><li class=\"plainItem\"><a sectionName=\"Dosage Forms\" href=\"#F151195\" class=\"outlineLink\">Dosage Forms</a></li><li class=\"plainItem\"><a sectionName=\"Generic Availability (US)\" href=\"#F151182\" class=\"outlineLink\">Generic Availability (US)</a></li><li class=\"plainItem\"><a sectionName=\"Administration\" href=\"#F1005736\" class=\"outlineLink\">Administration</a></li><li class=\"plainItem\"><a sectionName=\"Storage/Stability\" href=\"#F151209\" class=\"outlineLink\">Storage/Stability</a></li><li class=\"plainItem\"><a sectionName=\"Use\" href=\"#F1005708\" class=\"outlineLink\">Use</a></li><li class=\"plainItem\"><a sectionName=\"Adverse Reactions\" href=\"#F151248\" class=\"outlineLink\">Adverse Reactions</a></li><li class=\"plainItem\"><a sectionName=\"Contraindications\" href=\"#F151200\" class=\"outlineLink\">Contraindications</a></li><li class=\"plainItem\"><a sectionName=\"Warnings/Precautions\" href=\"#F151186\" class=\"outlineLink\">Warnings/Precautions</a></li><li class=\"plainItem\"><a sectionName=\"Warnings: Additional Pediatric Considerations\" href=\"#F26522861\" class=\"outlineLink\">Warnings: Additional Pediatric Considerations</a></li><li class=\"plainItem\"><a sectionName=\"Metabolism/Transport Effects\" href=\"#F13299041\" class=\"outlineLink\">Metabolism/Transport Effects</a></li><li class=\"plainItem\"><a sectionName=\"Drug Interactions\" href=\"#F151190\" class=\"outlineLink\">Drug Interactions</a></li><li class=\"plainItem\"><a sectionName=\"Pregnancy Risk Factor\" href=\"#F151192\" class=\"outlineLink\">Pregnancy Risk Factor</a></li><li class=\"plainItem\"><a sectionName=\"Pregnancy Implications\" href=\"#F151202\" class=\"outlineLink\">Pregnancy Implications</a></li><li class=\"plainItem\"><a sectionName=\"Monitoring Parameters\" href=\"#F5598923\" class=\"outlineLink\">Monitoring Parameters</a></li><li class=\"plainItem\"><a sectionName=\"Mechanism of Action\" href=\"#F151185\" class=\"outlineLink\">Mechanism of Action</a></li><li class=\"plainItem\"><a sectionName=\"Pharmacodynamics/Kinetics (Adult data unless noted)\" href=\"#F151199\" class=\"outlineLink\">Pharmacodynamics/Kinetics (Adult data unless noted)</a></li><li class=\"plainItem\"><a sectionName=\"Pricing: US\" href=\"#F151201\" class=\"outlineLink\">Pricing: US</a></li><li class=\"plainItem\"><a sectionName=\"Brand Names: International\" href=\"#F151203\" class=\"outlineLink\">Brand Names: International</a></li><li class=\"plainItem\"><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"DRUG_PED/13063|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=DRUG/57469\" class=\"graphic graphic_table\">- Lexicomp clinical abbreviations</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li><a href=\"topic.htm?path=ciclopirox-drug-information\" class=\"drug drug_general\">Ciclopirox: Drug information</a></li><li><a href=\"topic.htm?path=ciclopirox-patient-drug-information\" class=\"drug drug_patient\">Ciclopirox: Patient drug information</a></li></ul></div></div>","javascript":null}